Suppr超能文献

一种新的甘草次酸类似物(BX24)、硫酸锌和维生素A治疗胃溃疡的临床试验。

Clinical trial of a new carbenoxolone analogue (BX24), zinc sulphate, and vitamin A in the treatment of gastric ulcer.

作者信息

Fraser P M, Doll R, Langman M J, Misiewicz J J, Shawdon H H

出版信息

Gut. 1972 Jun;13(6):459-63. doi: 10.1136/gut.13.6.459.

Abstract

The effects of a new carbenoxolone analogue (BX24), zinc sulphate, and vitamin A on the healing of gastric ulcer have been assessed in a multifactorial clinical trial conducted in out-patients treated for four weeks.Forty-eight patients completed the trial. Three groups of eight patients were given respectively 300, 600, and 1 200 mg of BX24 daily and were compared with 24 patients who were given 300 mg of carbenoxolone sodium daily. The size of the ulcer niche was reduced on average by 14.6% in the eight patients given BX24 300 mg daily, by 47.6% in the patients given 600 mg daily, and by 51.0% in the patients given 1 200 mg daily. In the patients given carbenoxolone the size of the niche was reduced by 68.9%. These results were compared with those obtained previously with carbenoxolone and inert tablets and it was concluded that BX24 is without clinically useful effect in the doses used. Eleven of the 24 patients (46%) treated with carbenoxolone sodium developed side effects due to fluid retention and electrolyte disturbances. None of the patients given BX24 experienced such effects. In addition to carbenoxolone or BX24, 24 patients were given zinc sulphate, 660 mg daily, and in 24 patients these tablets were withheld. Among the patients given carbenoxolone the reduction in the size of the niche was much the same irrespective of whether or not the patients received zinc sulphate. Among the 12 patients given BX24 with zinc sulphate the ulcer healed completely in four and, on average, the size of the niche was reduced by 53.5%, compared with 21.9% in the 12 patients given BX24 alone. This difference is not statistically significant but the possibility of a beneficial effect from zinc is not excluded. No side effects attributable to zinc were observed.Twenty-four patients were also given vitamin A, 50 000 units daily, and in 24 patients the vitamin was withheld. No evidence was obtained to suggest that vitamin A had any beneficial effect on the healing of gastric ulcer.

摘要

在一项针对门诊患者进行的为期四周的多因素临床试验中,评估了一种新的甘草次酸类似物(BX24)、硫酸锌和维生素A对胃溃疡愈合的影响。48名患者完成了试验。三组每组8名患者分别每日服用300、600和1200毫克BX24,并与24名每日服用300毫克甘草次酸钠的患者进行比较。每日服用300毫克BX24的8名患者中,溃疡龛平均缩小14.6%;每日服用600毫克的患者中,溃疡龛缩小47.6%;每日服用1200毫克的患者中,溃疡龛缩小51.0%。服用甘草次酸的患者中,溃疡龛缩小68.9%。将这些结果与先前使用甘草次酸和惰性片剂获得的结果进行比较,得出结论:所用剂量的BX24无临床有益效果。24名服用甘草次酸钠的患者中有11名(46%)因液体潴留和电解质紊乱出现副作用。服用BX24的患者均未出现此类影响。除了甘草次酸或BX24外,24名患者每日服用660毫克硫酸锌,另外24名患者未服用这些片剂。在服用甘草次酸的患者中,无论是否接受硫酸锌,溃疡龛的缩小程度大致相同。在12名服用BX24和硫酸锌的患者中,4例溃疡在四周内完全愈合,溃疡龛平均缩小53.5%,而12名单独服用BX24的患者中,溃疡龛平均缩小21.9%。这种差异无统计学意义,但不排除锌有有益作用的可能性。未观察到归因于锌的副作用。另外24名患者每日服用50000单位维生素A,另外24名患者未服用该维生素。未获得证据表明维生素A对胃溃疡愈合有任何有益作用。

相似文献

7
Carbenoxolone sodium.甘草次酸钠
Gut. 1968 Feb;9(1):5-6. doi: 10.1136/gut.9.1.5.
9
Carbenoxolone sodium and gastric ulcer.甘草次酸钠与胃溃疡
Med J Aust. 1972 Aug 19;2(8):401. doi: 10.5694/j.1326-5377.1972.tb47379.x.

引用本文的文献

2
Vascular remodeling and mineralocorticoids.血管重塑与盐皮质激素
J Endocrinol Invest. 1995 Jul-Aug;18(7):533-9. doi: 10.1007/BF03349764.
4
The controlled trial.对照试验。
Postgrad Med J. 1984 Nov;60(709):719-24. doi: 10.1136/pgmj.60.709.719.
5
Medical management of peptic ulcer.消化性溃疡的药物治疗
Postgrad Med J. 1984 Nov;60(709):751-9. doi: 10.1136/pgmj.60.709.751.
9
Carbenoxolone sodium.甘草次酸钠
Gut. 1972 Oct;13(10):816-24. doi: 10.1136/gut.13.10.816.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验